. 2022 Aug 19;71(33):1042–1046. doi: 10.15585/mmwr.mm7133a2

TABLE 1. Estimated coverage* with the first and second dose of measles-containing vaccine, vaccination schedule,^† number of reported measles cases,^§ and measles incidence,^¶^,** by country — World Health Organization South-East Asia Region, 2003 and 2020.

Country	2003						2020						% Change, 2003–2020
	MCV schedule^† and vaccine type		WHO/UNICEF estimated coverage,* %		No. of reported measles cases^§	Measles incidence^¶,**	MCV schedule^† and vaccine type		WHO/UNICEF estimated coverage,* %		No. of reported measles cases^§	Measles incidence^¶,**	MCV1 coverage	Measles incidence**
	MCV1	MCV2	MCV1	MCV2	No. of reported measles cases^§	Measles incidence^¶,**	MCV1	MCV2	MCV1	MCV2	No. of reported measles cases^§	Measles incidence^¶,**	MCV1 coverage	Measles incidence**
Bangladesh	M, 9 mos	—^††	76	—^††	4,067	29.8	MR, 9 mos	MR, 15 mos	97	93	2,410	14.4	28	−52
Bhutan	M, 9 mos	—^††	88	—^††	0	0.0	MMR, 9 mos	MMR, 24 mos	93	92	0	0.0	6	0
Burma^§§	M, 9 mos	—^††	80	—^††	830	17.7	MR, 9 mos	MR, 18 mos	91	90	444	8.3	14	−53
India	M, 9 mos	—^††	60	—^††	47,147	42.2	MR, 9 mos	MR, 16–24 mos	89	81	5,604	4.0	48	−91
Indonesia	M, 9 mos	M, 7 yrs^¶¶	74	21^¶¶	24,457	109.6	MR, 9 mos	MR, 18 mos***	76	60	524	1.9	3	−98
Maldives	M, 9 mos	—^††	96	—^††	75	252.3	MR, 9 mos	MMR, 18 mos	99	96	15	29.2	3	−88
Nepal	M, 9 mos	—^††	75	—^††	13,344	519.6	MR, 9 mos	MR, 15 mos	87	74	388	13.2	16	−97
North Korea	M, 9 mos	—^††	95	—^††	0	0.0	MR, 9 mos	MR, 15 mos	99	99	0	0.0	4	0
Sri Lanka	M, 9–12 mos^†††	MR, 3 yrs	99	90	65	3.4	MMR, 1 yr	MMR, 3 yrs	96	96	2	0.1	−3	−97
Thailand	M, 9 mos	MMR, 6 yrs	96	92	4,519	69.8	MMR, 9 mos	MMR, 2.5 yrs	96	87	NR^§§§	—^¶¶¶	0	—^¶¶¶
Timor-Leste	M, 9 mos	—^††	55	—^††	94	101.4	MR, 9 mos	MR, 18 mos	79	78	2	1.5	44	−99
Region overall	NA	NA	65	6	94,598	57.0	NA	NA	88	80	9,389	4.8	35	−92

Abbreviations: JRF = Joint Reporting Form; M = measles; MCV = measles-containing vaccine; MCV1 = first dose of MCV in routine immunization; MCV2 = second dose of MCV in routine immunization; MMR = measles-mumps-rubella; MR = measles-rubella; NA = not applicable; NR = not reported; WHO = World Health Organization.

* Data were from WHO and UNICEF estimates, 2021 revision (as of July 2022). http://immunizationdata.who.int

^† As reported to WHO/UNICEF on JRFs for the year.

^§ JRF was submitted to WHO and UNICEF by member states with the official immunization data and the number of measles cases in the country for the year.

^¶ Measles incidence is calculated based on the reported measles cases and population by member states through WHO/UNICEF JRF.

** Cases per 1 million population.

^†† MCV2 was not introduced into routine immunization.

^§§ MMWR uses the U.S. Department of State’s short-form name “Burma”; WHO uses “Myanmar.”

^¶¶ Subnational introduction in schools of West Java at age 7 years.

*** MCV third dose administered in schools at grade 1.

^††† Changed in 2011 from age 9 months to 9–12 months.

^§§§ Thailand did not report measles case data to the JRF in 2020.

^¶¶¶ Could not be calculated.

TABLE 1. Estimated coverage* with the first and second dose of measles-containing vaccine, vaccination schedule,† number of reported measles cases,§ and measles incidence,¶,** by country — World Health Organization South-East Asia Region, 2003 and 2020.

TABLE 1. Estimated coverage* with the first and second dose of measles-containing vaccine, vaccination schedule,^† number of reported measles cases,^§ and measles incidence,^¶^,** by country — World Health Organization South-East Asia Region, 2003 and 2020.